Seres Therapeutics: Seres Receives $50 Mln Installment Payment Towards Sale Of VOWST Business To Nestle Health Science
(RTTNews) - Seres Therapeutics, Inc. (MCRB), a live biotherapeutics company, Thursday said that it has received a $50 million installment payment related to the sale of its VOWST business to Nestle Health Science.
Read full article »
Seres Therapeutics is a Massachusetts-based biotechnology company that researches and develops novel microbiome therapeutics for the treatment of gastrointestinal infections.
Read more